WELL Health Technologies Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA94947L1022
CAD
3.99
0.32 (8.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.7 M

Shareholding (Sep 2022)

FII

0.41%

Held by 1 FIIs

DII

99.59%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Healthy long term growth as Net Sales has grown by an annual rate of 95.03% and Operating profit at 1.62%

 
2

With a growth in Operating Profit of 82.32%, the company declared Very Positive results in Sep 24

3

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 1,300 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.55

stock-summary
Return on Equity

-7.35%

stock-summary
Price to Book

1.57

Revenue and Profits:
Net Sales:
357 Million
(Quarterly Results - Jun 2025)
Net Profit:
17 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.01%
0%
-14.01%
6 Months
-1.24%
0%
-1.24%
1 Year
-38.71%
0%
-38.71%
2 Years
2.31%
0%
2.31%
3 Years
29.97%
0%
29.97%
4 Years
-22.52%
0%
-22.52%
5 Years
-42.75%
0%
-42.75%

WELL Health Technologies Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
95.03%
EBIT Growth (5y)
1.62%
EBIT to Interest (avg)
-0.72
Debt to EBITDA (avg)
3.53
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.71
Tax Ratio
44.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.41%
ROCE (avg)
1.44%
ROE (avg)
0.27%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.56
EV to EBIT
-311.88
EV to EBITDA
22.36
EV to Capital Employed
1.36
EV to Sales
1.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.44%
ROE (Latest)
-7.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2022stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.41%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 46.73% vs 42.25% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -85.47% vs 5,950.00% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "356.70",
          "val2": "243.10",
          "chgp": "46.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "54.30",
          "val2": "31.40",
          "chgp": "72.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.70",
          "val2": "9.60",
          "chgp": "32.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.90",
          "val2": "112.00",
          "chgp": "-93.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17.00",
          "val2": "117.00",
          "chgp": "-85.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "81.00%",
          "val2": "58.10%",
          "chgp": "2.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.50% vs 36.37% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 75.30% vs -11.23% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "919.70",
          "val2": "776.10",
          "chgp": "18.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "52.90",
          "val2": "101.90",
          "chgp": "-48.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "36.90",
          "val2": "32.30",
          "chgp": "14.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "82.60",
          "val2": "14.60",
          "chgp": "465.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "29.10",
          "val2": "16.60",
          "chgp": "75.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-21.10%",
          "val2": "53.00%",
          "chgp": "-7.41%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
356.70
243.10
46.73%
Operating Profit (PBDIT) excl Other Income
54.30
31.40
72.93%
Interest
12.70
9.60
32.29%
Exceptional Items
6.90
112.00
-93.84%
Consolidate Net Profit
17.00
117.00
-85.47%
Operating Profit Margin (Excl OI)
81.00%
58.10%
2.29%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 46.73% vs 42.25% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -85.47% vs 5,950.00% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
919.70
776.10
18.50%
Operating Profit (PBDIT) excl Other Income
52.90
101.90
-48.09%
Interest
36.90
32.30
14.24%
Exceptional Items
82.60
14.60
465.75%
Consolidate Net Profit
29.10
16.60
75.30%
Operating Profit Margin (Excl OI)
-21.10%
53.00%
-7.41%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 18.50% vs 36.37% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 75.30% vs -11.23% in Dec 2023

stock-summaryCompany CV
About WELL Health Technologies Corp. stock-summary
stock-summary
WELL Health Technologies Corp.
Pharmaceuticals & Biotechnology
WELL Health Technologies Corp is a Canada-based omni-channel digital health company. The Company is primarily engaged in operating primary healthcare facilities, as well as an electronic medical records (EMR) business. The Company provides software as a service (SaaS) EMR services to doctors across Canada. It operates as a national telehealth service and is a provider of digital health, billing and cybersecurity related technology solutions. The Company owns and operates over 20 medical clinics and provides digital EMR software and services to over 2,000 medical clinics across Canada. Its clinics offers a range of services such as walk in appointments, family medicine, sleep apnea facilities, Botox treatments, and women’s clinics. It operates clinics across various cities, including Surrey, Vancouver, North Vancouver, Richmond and Coquitlam. The Company is also engaged in the business of providing secure clinic management, telehealth and practice management software related services.
Company Coordinates stock-summary
Company Details
Suite 200, 322 Water Street , VANCOUVER BC : V6B 1B6
stock-summary
Tel: 1 604 6287266
stock-summary
Registrar Details